Synthesis and biological evaluation of diversely substituted indolin-2-ones. 2008

Fadoua Bouchikhi, and Emilie Rossignol, and Martine Sancelme, and Bettina Aboab, and Fabrice Anizon, and Doriano Fabbro, and Michelle Prudhomme, and Pascale Moreau
Laboratoire SEESIB, Université Blaise Pascal, UMR 6504 du CNRS, 24 avenue des Landais, F-63177 Aubière Cedex, France.

The synthesis of indolin-2-one derivatives substituted in the 3-position by an aminomethylene group bearing either an ornithine or a lysine residue is described. The inhibitory activities of these compounds toward a panel of eight kinases were examined. Furthermore, the antibacterial activities of the prepared compounds were tested against two Gram-positive bacteria Bacillus cereus and Streptomyces chartreusis, a Gram-negative bacterium Escherichia coli and a yeast Candida albicans.

UI MeSH Term Description Entries
D007211 Indoles Benzopyrroles with the nitrogen at the number one carbon adjacent to the benzyl portion, in contrast to ISOINDOLES which have the nitrogen away from the six-membered ring.
D007536 Isomerism The phenomenon whereby certain chemical compounds have structures that are different although the compounds possess the same elemental composition. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 5th ed) Isomerisms
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D003198 Computer Simulation Computer-based representation of physical systems and phenomena such as chemical processes. Computational Modeling,Computational Modelling,Computer Models,In silico Modeling,In silico Models,In silico Simulation,Models, Computer,Computerized Models,Computer Model,Computer Simulations,Computerized Model,In silico Model,Model, Computer,Model, Computerized,Model, In silico,Modeling, Computational,Modeling, In silico,Modelling, Computational,Simulation, Computer,Simulation, In silico,Simulations, Computer
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D001686 Biological Phenomena Biological processes, properties, and characteristics of the whole organism in human, animal, microorganisms, and plants, and of the biosphere. Biological Processes,Biologic Phenomena,Biological Phenomenon,Biological Process,Phenomena, Biological,Phenomena, Biologic,Phenomenon, Biological,Process, Biological,Processes, Biological
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular
D047428 Protein Kinase Inhibitors Agents that inhibit PROTEIN KINASES. Protein Kinase Inhibitor,Inhibitor, Protein Kinase,Inhibitors, Protein Kinase,Kinase Inhibitor, Protein,Kinase Inhibitors, Protein
D050296 Microbial Viability Ability of a microbe to survive under given conditions. This can also be related to a colony's ability to replicate. Bacterial Viability,Virus Viability,Bacteria Viability,Microbial Inactivation,Inactivation, Microbial,Viability, Bacteria,Viability, Bacterial,Viability, Microbial,Viability, Virus

Related Publications

Fadoua Bouchikhi, and Emilie Rossignol, and Martine Sancelme, and Bettina Aboab, and Fabrice Anizon, and Doriano Fabbro, and Michelle Prudhomme, and Pascale Moreau
May 2014, European journal of medicinal chemistry,
Fadoua Bouchikhi, and Emilie Rossignol, and Martine Sancelme, and Bettina Aboab, and Fabrice Anizon, and Doriano Fabbro, and Michelle Prudhomme, and Pascale Moreau
January 2007, Journal of combinatorial chemistry,
Fadoua Bouchikhi, and Emilie Rossignol, and Martine Sancelme, and Bettina Aboab, and Fabrice Anizon, and Doriano Fabbro, and Michelle Prudhomme, and Pascale Moreau
August 2017, Bioorganic & medicinal chemistry letters,
Fadoua Bouchikhi, and Emilie Rossignol, and Martine Sancelme, and Bettina Aboab, and Fabrice Anizon, and Doriano Fabbro, and Michelle Prudhomme, and Pascale Moreau
October 2015, Bioorganic & medicinal chemistry letters,
Fadoua Bouchikhi, and Emilie Rossignol, and Martine Sancelme, and Bettina Aboab, and Fabrice Anizon, and Doriano Fabbro, and Michelle Prudhomme, and Pascale Moreau
November 2011, Molecules (Basel, Switzerland),
Fadoua Bouchikhi, and Emilie Rossignol, and Martine Sancelme, and Bettina Aboab, and Fabrice Anizon, and Doriano Fabbro, and Michelle Prudhomme, and Pascale Moreau
June 2018, Organic & biomolecular chemistry,
Fadoua Bouchikhi, and Emilie Rossignol, and Martine Sancelme, and Bettina Aboab, and Fabrice Anizon, and Doriano Fabbro, and Michelle Prudhomme, and Pascale Moreau
November 2006, Journal of the American Chemical Society,
Fadoua Bouchikhi, and Emilie Rossignol, and Martine Sancelme, and Bettina Aboab, and Fabrice Anizon, and Doriano Fabbro, and Michelle Prudhomme, and Pascale Moreau
January 2023, Future medicinal chemistry,
Fadoua Bouchikhi, and Emilie Rossignol, and Martine Sancelme, and Bettina Aboab, and Fabrice Anizon, and Doriano Fabbro, and Michelle Prudhomme, and Pascale Moreau
December 2023, Molecules (Basel, Switzerland),
Fadoua Bouchikhi, and Emilie Rossignol, and Martine Sancelme, and Bettina Aboab, and Fabrice Anizon, and Doriano Fabbro, and Michelle Prudhomme, and Pascale Moreau
May 1996, Journal of medicinal chemistry,
Copied contents to your clipboard!